This content is from: Patents

Merck’s $200m patent damages award voided after “misconduct”

Northern District of California judge rules Merck forfeited its right to assert patents against Gilead because of "unclean hands" and "numerous unconscionable acts", voiding the second-largest US patent damages award of 2016 so far

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.

Related